Dexcom submits new sensor to FDA, expects summer launch
Dexcom announced that it submitted its new Stelo glucose sensor to the FDA for review at the end of last year.
Source: massdevice.com
Stay updated with breaking news from Dexcom Chair. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Dexcom announced that it submitted its new Stelo glucose sensor to the FDA for review at the end of last year.
Dexcom (Nasdaq:DXCM) today unveiled its strategy to expand access to its glucose-sensing technology for millions around the world.
The CEO of Dexcom (Nasdaq:DXCM) said today that the company's regulatory path for the next-generation G7 has been slightly delayed.